JD

Jay Dinesh Pambhar

Active Director Director DIN 10939954
DIN 10939954 First appointment Feb 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value •••• Premium profile

About Jay Dinesh Pambhar

Data last updated:

Jay Dinesh Pambhar is a Director at Newage Medisys Limited (since 2025). The company operates in Healthcare. Newage Medisys Limited reported revenue of ₹8.57 Cr (FY 2025).

DIN 10939954
Primary Designation Director
Industry Healthcare
First Appointment 06 Feb 2025
Oldest Company Age 1 yrs
Largest company Newage Medisys Limited · ₹8.57 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Newage Medisys Limited U32503GJ2025PLC158656
Director06 Feb 20252025₹8.57 Cr (FY 2025)Active

Board colleagues of Jay Dinesh Pambhar

Directorship timeline

Open interactive timeline →
Newage Medisys Limited
Premium access

Shareholding and investment profile for Jay Dinesh Pambhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jay Dinesh Pambhar

Jay Dinesh Pambhar currently holds 1 directorship: Newage Medisys Limited (Director, since 06 Feb 2025, revenue ₹8.57 Cr (FY 2025)).

Jay Dinesh Pambhar was first appointed on 06 Feb 2025 as Director at Newage Medisys Limited.

The current boards of Jay Dinesh Pambhar's companies include Divyesh Karamshibhai Pambhar (Newage Medisys Limited), Jalviben Divyeshbhai Pambhar (Newage Medisys Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available